Evommune, Inc.EVMNEarnings & Financial Report

NYSE · Health Care · Pharmaceutical Preparations

Deep AnalysisCompare

Evommune, Inc. is a clinical-stage biotechnology company focused on developing innovative therapies for chronic inflammatory and immunological diseases. Its pipeline includes novel candidates targeting unmet medical needs for conditions such as atopic dermatitis, psoriasis, and other immune-mediated disorders, primarily serving global healthcare markets.